Somnomed Ltd
ASX:SOM
Somnomed Ltd
Capital Expenditures
Somnomed Ltd
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Somnomed Ltd
ASX:SOM
|
Capital Expenditures
-AU$4.5m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-28%
|
|
ImpediMed Ltd
ASX:IPD
|
Capital Expenditures
-AU$5m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-56%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Capital Expenditures
-AU$538k
|
CAGR 3-Years
0%
|
CAGR 5-Years
8%
|
CAGR 10-Years
2%
|
Cochlear Ltd
ASX:COH
|
Capital Expenditures
-AU$95.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-11%
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Capital Expenditures
-AU$37.7k
|
CAGR 3-Years
-12%
|
CAGR 5-Years
30%
|
CAGR 10-Years
-14%
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Capital Expenditures
-AU$187.3k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Somnomed Ltd's Capital Expenditures?
Capital Expenditures
-4.5m
AUD
Based on the financial report for Dec 31, 2023, Somnomed Ltd's Capital Expenditures amounts to -4.5m AUD.
What is Somnomed Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-28%
Over the last year, the Capital Expenditures growth was 54%. The average annual Capital Expenditures growth rates for Somnomed Ltd have been -20% over the past three years , -22% over the past five years , and -28% over the past ten years .